Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge
Edward Sullivan, Po-Yu Sung, Weining Wu, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 914-914
Open Access | Times Cited: 17

Showing 17 citing articles:

Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system
Luis Giovani de Oliveira Guardalini, Felipe Moura Dias, Samanta Omae Camalhonte, et al.
Biotechnology Letters (2025) Vol. 47, Iss. 2
Closed Access
Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human
Jinghua Yuan, Jingyu Chen, Qingzhi Zhao, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
The Application of DNA Viruses to Biotechnology
Adam J. Schieferecke, Norbert Ralph, David V. Schaffer
Viruses (2025) Vol. 17, Iss. 3, pp. 414-414
Open Access
Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection
Yamil E. Masip, Lucas D. Caeiro, Maximiliano Cosenza, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
Multi-Gene Recombinant Baculovirus Expression Systems: From Inception to Contemporary Applications
Sara L. Bissett, Polly Roy
Viruses (2024) Vol. 16, Iss. 4, pp. 492-492
Open Access | Times Cited: 3
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
Marcel Jaron, Michael Lehky, M Zara, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 14
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
Stefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1469-1469
Open Access | Times Cited: 7
Strengths and limitations of SARS-CoV-2 virus-like particle systems
Rokaia Sultana, Robert V. Stahelin
Virology (2024) Vol. 601, pp. 110285-110285
Open Access | Times Cited: 1
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
Journal of Virological Methods (2023) Vol. 322, pp. 114835-114835
Open Access | Times Cited: 3
Porcine Deltacoronavirus-like Particles Produced by a Single Recombinant Baculovirus Elicit Virus-Specific Immune Responses in Mice
Yangkun Liu, Xueying Han, Yaqi Qiao, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 2
Soluble SARS‐CoV‐2 RBD and human ACE2 peptidase domain produced in DrosophilaS2 cells show functions evoking virus–cell interface
Federico Carrión, Florencia Rammauro, Natalia Olivero‐Deibe, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 2
Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
Andrew J. Zak, Trang Hoang, Christine M. Yee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14622-14622
Open Access | Times Cited: 2
Virus-Like Particles as Viral Vaccines: From Inception to Contemporary Applications
Sara L. Bissett, Polly Roy
(2024)
Open Access
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
Edmund G. Wee, Sarah Kempster, David Ferguson, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 965-965
Open Access
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
Grace Neilsen, Asha Maria Mathew, J.M. Castro, et al.
mBio (2024)
Open Access
Characterization and application of recombinant Bovine Leukemia Virus Env protein
Lorena Tomé-Poderti, Natalia Olivero‐Deibe, Federico Carrión, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Vaccine against Trypanosoma cruzi infection using the Parasite Antigen TcTASV Displayed at Baculovirus Capsid
Valeria Tekiel, Yamil E. Masip, Lucas D. Caeiro, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top